Location: San Francisco, CA
CIK: 0001977548 · Show all filings
Period: Q1 2025 (← Previous) (Next →)
Filing Date: May 15, 2025
Total Value: $182M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ARGX | ARGENX SE | 115,000 | $68.06M | 37.3% | $437.74 | — | SPONSORED ADR | 04016X101 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 907,240 | $48.06M | 26.4% | $39.53 | +40.3% | COM | 76243J105 |
| RVMD | REVOLUTION MEDICINES INC | 392,011 | $13.86M | 7.6% | $45.88 | -11.5% | COM | 76155X100 |
| SLNO | SOLENO THERAPEUTICS INC | 172,902 | $12.35M | 6.8% | $48.01 | +1.4% | COM | 834203309 |
| IRON | DISC MEDICINE INC | 243,311 | $12.08M | 6.6% | $56.16 | -1.0% | COM | 254604101 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 175,184 | $8.472M | 4.6% | $41.90 | 0.0% | COM | 74366E102 |
| STOK | STOKE THERAPEUTICS INC | 730,717 | $4.859M | 2.7% | $10.97 | -15.0% | COM | 86150R107 |
| SEPN | SEPTERNA INC | 824,878 | $4.776M | 2.6% | $11.42 | 0.0% | COM | 81734D104 |
| KYMR | KYMERA THERAPEUTICS INC | 136,605 | $3.739M | 2.1% | $41.40 | -11.9% | COM | 501575104 |
| TCRX | TSCAN THERAPEUTICS INC | 2,017,650 | $2.784M | 1.5% | $4.84 | -55.3% | COM | 89854M101 |
| — | CIDARA THERAPEUTICS INC | 104,380 | $2.248M | 1.2% | $12.75 | — | COM NEW | 171757206 |
| CORT | CORCEPT THERAPEUTICS INC | 5,000 | $571K | 0.3% | $60.87 | 0.0% | COM | 218352102 |
| IMCR | IMMUNOCORE HLDGS PLC | 9,011 | $267K | 0.1% | $29.67 | — | ADS | 45258D105 |
| — | RAPT THERAPEUTICS INC | 109,830 | $134K | 0.1% | $1.22 | — | COM | 75382E109 |